## NOC: Northrop Grumman Corporation - XLI: Industrials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.9% in lower entry zone (3.0-6.0%), top quartile (77th pct) cross-sectional ranking. Short-term MRS_5 (2.6%) confirms momentum alignment. Strong momentum (+4.2% 5-day acceleration).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($587.41)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Northrop Grumman to design electronic controls for launch systems on ballistic missile submarines**
- Source: Military Aerospace | 20260106T074041 | Somewhat-Bullish | Relevance: 100%
- Northrop Grumman has secured a $120 million contract from the U.S. Navy to provide long-lead materials for the Columbia Development Launcher Program (CDLP). This program supports the missile launch systems for future Columbia-class and UK Dreadnought-class nuclear ballistic missile submarines, which will carry Trident II D5 nuclear missiles. The contract emphasizes the development and production of launcher subsystem hardware, ensuring the reliability of these next-generation naval deterrents.

**2. Assessing Northrop Grumman (NOC) Valuation As Key Defense Programs Draw Renewed Attention**
- Source: Simply Wall Street | 20260105T183441 | Somewhat-Bullish | Relevance: 100%
- Northrop Grumman (NOC) is gaining significant attention due to its involvement in key Pentagon programs, prompting an assessment of its valuation. While a popular narrative suggests an 11.6% undervaluation with a fair value of $662.68 due to robust defense cash flows and program ramps, a Discounted Cash Flow (DCF) model indicates potential overvaluation at a fair value of $512.83 against its current share price of $585.66. The article encourages investors to consider both perspectives and conduct their own research into the company's financial health, risks, and growth prospects.

**3. Morgan Stanley says buy these defense stocks post Venezuela and Iran**
- Source: CNBC | 20260106T195504 | Bullish | Relevance: 86%
- Morgan Stanley suggests buying defense stocks due to rising geopolitical tensions, particularly after recent U.S. military actions in Venezuela and Iran. Despite trading at a discount, the sector is expected to benefit from increased military spending, especially in areas like 3D printing for drone manufacturing. Northrop Grumman is highlighted as the top pick, with RTX, L3Harris Technologies, and General Dynamics also favored.

**4. Who Will Build President Trump's New Golden Fleet Battleships?**
- Source: Finviz | 20260104T072700 | Somewhat-Bullish | Relevance: 83%
- President Trump plans to introduce a new "Trump-class" battleship, the USS Defiant, described as the most lethal surface combatant ever constructed, with an estimated cost of $9 billion or more. This article discusses the advanced weaponry this battleship will possess, including hypersonic missiles, electromagnetic railguns, and laser cannons. It also explores which major defense contractors like Huntington Ingalls Industries, General Dynamics, Boeing, Northrop Grumman, and RTX Corporation are likely to be involved in its construction.

**5. Noble Financial Sticks to Its Buy Rating for V2X (VVX)**
- Source: The Globe and Mail | 20260104T140918 | Neutral | Relevance: 65%
- Noble Financial analyst Joe Gomes has reaffirmed a Buy rating for V2X (VVX) with a price target of $72.00. The company reported strong quarterly revenue growth, reaching $1.17 billion, though corporate insider sentiment shows an increase in selling activity. The analyst consensus on V2X remains a Moderate Buy with an average price target of $64.29.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Morgan Stanley | $714 | $720 | -1% |
| 2025-12-15 | Alembic Global | $662 | $0 | 0% |
| 2025-12-12 | Citigroup | $654 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Morgan Stanley | main | Overweight |
| 2025-12-15 | Alembic Global | up | Overweight |
| 2025-12-12 | Citigroup | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+0.8%)
- State Street Corpora: 9.3% (-1.6%)
- Capital Internationa: 8.2% (-1.7%)
- Blackrock Inc.: 6.9% (+1.0%)
- JPMORGAN CHASE & CO: 3.9% (+91.5%)

### Key Risks

1. Valuation stretched: PEG 3.7x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_10 improving +4.2% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.69 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Balance sheet: $1.3B free cash flow. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $87.4B |
| Beta | 0.05 |
| 52W Range | $426.24 - $640.90 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.69 |
| Forward P/E | 21.2 |
| Current P/E | 23.4 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.3% to 3.9% (+4.2% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 77th percentile. MRS_5 at 2.6% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (4.44), confirming momentum. OFD pattern: -SBH (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.87% (CS: 78) | Strong |
| RSI_14 | 69.1 | Neutral |
| MACD Histogram | 4.44 | Bullish |
| vs SMA20 | 1.064x | Above |
| vs SMA50 | 1.070x | Above |
| vs SMA200 | 1.118x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $610.61
- **Stop Loss:** $587.41 (3.8% risk)
- **Target:** $645.41 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 56
- **Position Value:** $34,194.16
- **Portfolio %:** 34.19%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-01-29 (Est: $6.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.46 | $7.67 | +18.8% |
| 2025Q2 | $6.80 | $8.15 | +19.9% |
| 2025Q1 | $6.26 | $3.32 | -47.0% |
| 2024Q4 | $6.35 | $6.39 | +0.7% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_10*